Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,305 | 184 | 94.9% |
| Education | $341.69 | 5 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $801.01 | 26 | $0 (2024) |
| Dermavant Sciences, Inc. | $638.12 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $610.46 | 28 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $588.98 | 12 | $0 (2024) |
| UCB, Inc. | $447.48 | 12 | $0 (2024) |
| Lilly USA, LLC | $392.47 | 10 | $0 (2024) |
| GENZYME CORPORATION | $373.78 | 14 | $0 (2024) |
| PFIZER INC. | $336.93 | 10 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $297.46 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $269.32 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,429 | 167 | ABBVIE INC. ($655.96) |
| 2023 | $979.64 | 16 | ABBVIE INC. ($145.05) |
| 2022 | $152.57 | 2 | SCYNEXIS, Inc. ($88.56) |
| 2021 | $85.65 | 4 | GlaxoSmithKline, LLC. ($85.65) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.29 | General |
| Category: Immunology | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $5.92 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.43 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $2.07 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Immunology | ||||||
| 11/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $62.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $54.99 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $149.07 | General |
| Category: Immunology | ||||||
| 11/05/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $140.22 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: Dermatology | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.87 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $173.33 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $70.44 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 227 | 232 | $246,187 | $19,419 |
| 2022 | 6 | 556 | 583 | $561,537 | $50,764 |
| 2021 | 7 | 745 | 793 | $712,439 | $70,095 |
| 2020 | 5 | 412 | 415 | $381,039 | $34,721 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 88 | 90 | $133,230 | $10,998 | 8.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 34 | 34 | $64,710 | $5,140 | 7.9% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 41 | 42 | $43,467 | $2,952 | 6.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 64 | 66 | $4,780 | $329.52 | 6.9% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 237 | 242 | $349,990 | $31,468 | 9.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 53 | 53 | $97,713 | $9,342 | 9.6% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 76 | 79 | $78,440 | $6,141 | 7.8% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 33 | 34 | $19,040 | $1,673 | 8.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 27 | $5,994 | $1,335 | 22.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 142 | 148 | $10,360 | $804.92 | 7.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 336 | 353 | $482,973 | $46,330 | 9.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 62 | 63 | $110,539 | $10,636 | 9.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 70 | 70 | $66,995 | $5,921 | 8.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 51 | $11,322 | $2,555 | 22.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 36 | 36 | $19,198 | $1,802 | 9.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $7,476 | $1,675 | 22.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 198 | 208 | $13,936 | $1,177 | 8.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 208 | 211 | $275,556 | $25,592 | 9.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 55 | 55 | $49,815 | $3,866 | 7.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 23 | 23 | $38,088 | $3,759 | 9.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 22 | 22 | $10,924 | $895.86 | 8.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 104 | 104 | $6,656 | $607.12 | 9.1% |
About Andrea Alessi, PA
Andrea Alessi, PA is a Physician Assistant healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2017. The National Provider Identifier (NPI) number assigned to this provider is 1346759875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Andrea Alessi, PA has received a total of $6,647 in payments from pharmaceutical and medical device companies, with $5,429 received in 2024. These payments were reported across 189 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($6,305).
As a Medicare-enrolled provider, Alessi has provided services to 1,940 Medicare beneficiaries, totaling 2,023 services with total Medicare billing of $174,999. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Henderson, NV
- Active Since 09/27/2017
- Last Updated 06/12/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1346759875
Products in Payments
- DUPIXENT (Biological) $938.46
- TREMFYA (Drug) $759.53
- VTAMA (Drug) $638.12
- RINVOQ (Biological) $512.63
- Bimzelx (Biological) $447.48
- Sotyktu (Drug) $269.32
- SKYRIZI (Biological) $246.79
- TALTZ (Drug) $232.17
- Zoryve (Drug) $217.77
- LITFULO (Drug) $201.22
- OLUMIANT (Drug) $160.30
- Otezla (Drug) $151.14
- ILUMYA (Biological) $145.80
- ADBRY (Biological) $140.53
- CAPLYTA (Drug) $130.12
- XARELTO (Drug) $122.06
- OPZELURA (Drug) $121.74
- UPTRAVI (Drug) $116.82
- QUVIVIQ (Drug) $111.92
- JARDIANCE (Drug) $94.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Henderson
Anna Liang, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $9,518
Rachel Tennis, Pa-C, PA-C
Physician Assistant — Payments: $8,011
Stephanie Shibata, Pa-C, PA-C
Physician Assistant — Payments: $7,733
Benjamin Reese, Pa-C, PA-C
Physician Assistant — Payments: $6,807
Laurie Michlin, Apn, APN
Physician Assistant — Payments: $6,402
Daniel Salmon, Pa, PA
Physician Assistant — Payments: $6,367